Related Experiment Video
Updated: May 27, 2026

Intravitreal Injection and Quantitation of Infection Parameters in a Mouse Model of Bacterial Endophthalmitis
Published on: February 6, 2021
Fungal endophthalmitis
1Shiley Eye Center, University of California, San Diego, 9415 Campus Point Drive, La Jolla, CA 92093, USA. jay.chhablani@gmail.com
Abstract:
Fungal endophthalmitis (FE) is infrequent but results in poor visual outcomes. It can be exogenous or endogenous depending upon the mode of infection. The common causes for endogenous FE, post-traumatic FE and FE secondary to keratitis are Candida albicans, Aspergillus niger and Fusarium solani, respectively. Clinical features depend on the virulence of the organism and the mode of infection. Broad-spectrum systemic antifungal therapy with or without intravitreal antifungal drugs is recommended. The prognosis depends upon the virulence of the organism, extent of intraocular involvement and the timing of interventions. Prompt therapy following early diagnosis helps to reduce significant visual loss. This review evaluates the current literature on FE and focuses on antifungal agents and discusses species-specific management and outcomes of FE.
Insights
Fungal endophthalmitis (FE) is rare but causes vision loss. Prompt diagnosis and antifungal treatment, tailored to the specific fungus, improve outcomes for this serious eye infection.
Area of Science:
- Ophthalmology
- Mycology
- Infectious Diseases
Background:
- Fungal endophthalmitis (FE) is an uncommon ocular infection with significant visual morbidity.
- FE can be classified as exogenous or endogenous, with distinct causative agents and clinical presentations.
- Common fungal pathogens include Candida albicans, Aspergillus niger, and Fusarium solani, depending on the infection's origin.
Purpose of the Study:
- To review current literature on fungal endophthalmitis.
- To focus on effective antifungal agents and species-specific management strategies.
- To discuss the outcomes of various treatment approaches for FE.
Main Methods:
- Literature review of current research on fungal endophthalmitis.
- Analysis of clinical features, causative organisms, and treatment modalities.
- Evaluation of species-specific management and prognostic factors.
Main Results:
- Clinical features of FE vary based on fungal virulence and infection route.
- Systemic antifungal therapy, potentially combined with intravitreal agents, is the recommended treatment.
- Prognosis is influenced by pathogen virulence, extent of ocular involvement, and timeliness of intervention.
Conclusions:
- Early diagnosis and prompt, targeted antifungal therapy are crucial for reducing vision loss in FE.
- Management strategies should be adapted to the specific fungal species involved.
- Understanding species-specific characteristics is key to optimizing outcomes in fungal endophthalmitis.
Related Concept Videos
Endocarditis I: Introduction
Fungal Phylum Microsporidia
Endocarditis III: Medical Management
Endocarditis II: Clinical Features of Infective Endocarditis
Skin Diseases and Disorders
Gram-positive Staphylococcus spp. and Streptococcus spp. are responsible for many of the most common skin infections. However, many...
Glaucoma: Overview
